Dr. Xuan Thanh Le-Nguyen, MD

Dr. Le-Nguyen practices at Desert Eye Associates a Professional Corporation in Palm Desert, California.

Dr. Le-Nguyen's NPI, 1942593702, was assigned on May 25, 2011. Dr. Le-Nguyen graduated from The Johns Hopkins University School of Medicine in 2012. Dr. Le-Nguyen holds California license A150117.

Dr. Le-Nguyen's primary practice is Desert Eye Associates a Professional Corporation, at 37011 Cook St, Palm Desert, CA 92211 in Riverside County. The practice phone is (760) 342-6900.

Dr. Le-Nguyen's primary practice is Desert Eye Associates a Professional Corporation in Palm Desert, California. Dr. Le-Nguyen is also affiliated with Eisenhower Health. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Le-Nguyen to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Le-Nguyen practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Le-Nguyen's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Le-Nguyen is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Le-Nguyen's licenses on file in 2 states: California and New York.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. Le-Nguyen treats.

CMS data shows 2,840 Medicare services from Dr. Le-Nguyen across 17 procedure codes in 2024, for 571 Medicare patients. Medicare paid $205,696 for them.

CMS counts 571 Medicare patients who saw Dr. Le-Nguyen in 2024. The largest group is 75 to 84, with 242 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Le-Nguyen's median patient age at 76, with 47% women.

In 2024, Dr. Le-Nguyen wrote 1,932 Medicare Part D claims for 367 patients. 63% of them were for generic drugs. CMS names the drug for 1,849 of them, across 24 drugs with 11 or more claims each, at $224,976 in total drug cost. In 2023, CMS named 1,705 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Le-Nguyen for performance year 2024, reported as part of a group. Dr. Le-Nguyen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 185 procedures of cataract surgery by Dr. Le-Nguyen, more than 83% of the clinicians it reports for that procedure.

CMS Open Payments shows 39 general payments to Dr. Le-Nguyen from 12 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 52% of the total. Johnson & Johnson Surgical Vision, Inc. paid the most, $1,758.

Dr. Le-Nguyen graduated from The Johns Hopkins University School of Medicine in 2012.

Dr. Le-Nguyen is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.